Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001035948) NEUROPHILIN LIGANDS FOR TREATING OCULAR CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/035948 International Application No.: PCT/US2000/029320
Publication Date: 25.05.2001 International Filing Date: 24.10.2000
Chapter 2 Demand Filed: 25.05.2001
IPC:
A61K 31/00 (2006.01) ,A61K 31/4439 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4427
containing further heterocyclic ring systems
4439
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Applicants:
PANG, Iok-hou [US/US]; US (UsOnly)
HELLBERG, Mark, A. [US/US]; US (UsOnly)
NAMIL, Abdelmoula [FR/US]; US (UsOnly)
ALCON UNIVERSAL LTD. [CH/CH]; P.O. Box 62 Bosch 60 CH-6331 Hunenberg, CH (AllExceptUS)
Inventors:
PANG, Iok-hou; US
HELLBERG, Mark, A.; US
NAMIL, Abdelmoula; US
Agent:
YEAGER, Sally, S. ; Alcon Research, Ltd. R & D Counsel, Mail Code Q-148 6201 South Freeway Fort Worth, TX 76134, US
WAIN, Christopher, Paul; A.A. Thornton & Co. 235 High Holborn London WC1V 7LE, GB
Priority Data:
60/165,13712.11.1999US
Title (EN) NEUROPHILIN LIGANDS FOR TREATING OCULAR CONDITIONS
(FR) LIGANDS DE LA NEUROPHILINE POUR TRAITEMENT DE TROUBLES OCULAIRES
Abstract:
(EN) The use of neurophilin ligands for treating glaucoma and lowering IOP is disclosed.
(FR) L'invention concerne des ligands de la neurophiline destinés à traiter le glaucome et à réduire la pression intraoculaire élevée (PIO).
front page image
Designated States: AU, BR, CA, CN, JP, MX, PL, TR, US, ZA
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)